U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 261

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:116059643-129828703
GRCh38:
Chr2:115302067-129071130
AMMECR1L, BIN1, C1QL2, C2orf76, CCDC93, CFAP221, CLASP1, CNTNAP5, CNTNAP5-DT, CYP27C1, DBI, DDX18, DPP10, EN1, EPB41L5, ERCC3, GLI2, GPR17, GYPC, HS6ST1, INHBB, INSIG2, IWS1, LIMS2, LINC01101, LINC01823, LINC01826, LINC01889, LINC01941, LINC01956, LOC101927709, LOC101927881, LOC105373609, LOC107985939, LOC110120692, LOC110121228, LOC110121302, LOC112806040, LOC112806041, LOC112806043, LOC112806044, LOC112806045, LOC112806046, LOC115945186, LOC115945187, LOC115945188, LOC115945190, LOC120961781, LOC120961782, LOC120961783, LOC120961784, LOC121725101, LOC121725102, LOC121725103, LOC122819145, LOC122819146, LOC122819147, LOC122819148, LOC122819149, LOC122819150, LOC122819151, LOC122819152, LOC122819153, LOC126806318, LOC126806319, LOC126806320, LOC126806321, LOC126806322, LOC126806323, LOC126806324, LOC126806325, LOC126806326, LOC126806327, LOC126806328, LOC126806329, LOC126806330, LOC126806331, LOC126806332, LOC126806333, LOC126806334, LOC126806335, LOC126806336, LOC126806337, LOC126806338, LOC126806339, LOC126806340, LOC126806341, LOC126806342, LOC126806343, LOC126806344, LOC126806345, LOC126806346, LOC129388903, LOC129388904, LOC129388905, LOC129388906, LOC129388907, LOC129388908, LOC129388909, LOC129388910, LOC129388911, LOC129388912, LOC129388913, LOC129388914, LOC129388915, LOC129388916, LOC129388917, LOC129388918, LOC129934638, LOC129934639, LOC129934640, LOC129934641, LOC129934642, LOC129934643, LOC129934644, LOC129934645, LOC129934646, LOC129934647, LOC129934648, LOC129934649, LOC129934650, LOC129934651, LOC129934652, LOC129934653, LOC129934654, LOC129934655, LOC129934656, LOC129934657, LOC129934658, LOC129934659, LOC129934660, LOC129934661, LOC129934662, LOC129934663, LOC129934664, LOC129934665, LOC129934666, LOC129934667, LOC129934668, LOC129934669, LOC129934670, LOC129934671, LOC129934672, LOC129934673, LOC129934674, LOC129934675, LOC129934676, LOC129934677, LOC129934678, LOC129934679, LOC129934680, LOC129934681, LOC129934682, LOC129934683, LOC129934684, LOC129934685, LOC129934686, LOC129934687, LOC129934688, LOC129934689, LOC129934690, LOC129934691, LOC129934692, LOC129934693, LOC129934694, LOC129934695, LOC129934696, LOC129934697, LOC129934698, LOC129934699, LOC129934700, LOC129934701, LOC129934702, LOC129934703, LOC129934704, LOC129934705, LOC129934706, LOC129934707, LOC129934708, LOC129934709, LOC129934710, LOC129934711, LOC129934712, LOC129934713, LOC129934714, LOC129934715, LOC129934716, LOC129934717, LOC129934718, LOC129934719, LOC129934720, LOC129934721, LOC129934722, LOC129934723, LOC129934724, LOC129934725, LOC129934726, LOC129934727, LOC129934728, LOC129934729, LOC129934730, LOC129934731, LOC129934732, LOC129934733, LOC129934734, LOC129934735, LOC129934736, LOC129934737, LOC129934738, LOC129934739, LOC129934740, LOC129934741, LOC129934742, LOC129934743, LOC129934744, LOC129934745, LOC129934746, LOC129934747, LOC129934748, LOC129934749, LOC129934750, LOC129934751, LOC129934752, LOC129934753, LOC129934754, LOC129934755, LOC129934756, LOC129934757, LOC132088751, MAP3K2, MAP3K2-DT, MARCO, MIR4783, MYO7B, NIFK, NIFK-AS1, POLR2D, PROC, PTPN4, RALB, RNU4ATAC, SAP130, SCTR, SCTR-AS1, SFT2D3, STEAP3, STEAP3-AS1, TEX51, TFCP2L1, THORLNC, TMEM177, TMEM185B, TMEM37, TSN, UGGT1, WDR33
See casesPathogenic
(Oct 1, 2010)
no assertion criteria provided
2.
GRCh37:
Chr2:118843900-135722308
GRCh38:
Chr2:118086324-134964738
ACMSD, AMER3, AMMECR1L, ANKRD30BL, ARHGEF4, ARHGEF4-AS1, BIN1, C1QL2, C2orf27A, C2orf76, CCDC115, CCDC74A, CCDC74B, CCNT2, CCNT2-AS1, CDRT15P3, CFAP221, CFC1, CFC1B, CLASP1, CNTNAP5, CNTNAP5-DT, CYP27C1, DBI, EN1, EPB41L5, ERCC3, FAM168B, FAM201B, GLI2, GPR148, GPR17, GPR39, GYPC, HS6ST1, IMP4, INHBB, INSIG2, IWS1, LIMS2, LINC01087, LINC01101, LINC01120, LINC01823, LINC01826, LINC01854, LINC01856, LINC01889, LINC01941, LINC01945, LINC01956, LINC02572, LOC101927709, LOC101927881, LOC105373609, LOC108228197, LOC108228198, LOC108281157, LOC110120692, LOC110121228, LOC110121302, LOC112806041, LOC112806043, LOC112806044, LOC112806045, LOC112806046, LOC112806047, LOC112806048, LOC112806050, LOC115945186, LOC115945187, LOC115945188, LOC115945190, LOC115945197, LOC120961781, LOC120961782, LOC120961783, LOC120961784, LOC120961785, LOC121725101, LOC121725102, LOC121725103, LOC122819145, LOC122819146, LOC122819147, LOC122819148, LOC122819149, LOC122819150, LOC122819151, LOC122819152, LOC122819153, LOC122819154, LOC122819155, LOC122819156, LOC122819157, LOC122819158, LOC126806321, LOC126806322, LOC126806323, LOC126806324, LOC126806325, LOC126806326, LOC126806327, LOC126806328, LOC126806329, LOC126806330, LOC126806331, LOC126806332, LOC126806333, LOC126806334, LOC126806335, LOC126806336, LOC126806337, LOC126806338, LOC126806339, LOC126806340, LOC126806341, LOC126806342, LOC126806343, LOC126806344, LOC126806345, LOC126806346, LOC126806347, LOC126806348, LOC126806349, LOC126806350, LOC126806351, LOC126806352, LOC129388903, LOC129388904, LOC129388905, LOC129388906, LOC129388907, LOC129388908, LOC129388909, LOC129388910, LOC129388911, LOC129388912, LOC129388913, LOC129388914, LOC129388915, LOC129388916, LOC129388917, LOC129388918, LOC129388919, LOC129388920, LOC129934643, LOC129934644, LOC129934645, LOC129934646, LOC129934647, LOC129934648, LOC129934649, LOC129934650, LOC129934651, LOC129934652, LOC129934653, LOC129934654, LOC129934655, LOC129934656, LOC129934657, LOC129934658, LOC129934659, LOC129934660, LOC129934661, LOC129934662, LOC129934663, LOC129934664, LOC129934665, LOC129934666, LOC129934667, LOC129934668, LOC129934669, LOC129934670, LOC129934671, LOC129934672, LOC129934673, LOC129934674, LOC129934675, LOC129934676, LOC129934677, LOC129934678, LOC129934679, LOC129934680, LOC129934681, LOC129934682, LOC129934683, LOC129934684, LOC129934685, LOC129934686, LOC129934687, LOC129934688, LOC129934689, LOC129934690, LOC129934691, LOC129934692, LOC129934693, LOC129934694, LOC129934695, LOC129934696, LOC129934697, LOC129934698, LOC129934699, LOC129934700, LOC129934701, LOC129934702, LOC129934703, LOC129934704, LOC129934705, LOC129934706, LOC129934707, LOC129934708, LOC129934709, LOC129934710, LOC129934711, LOC129934712, LOC129934713, LOC129934714, LOC129934715, LOC129934716, LOC129934717, LOC129934718, LOC129934719, LOC129934720, LOC129934721, LOC129934722, LOC129934723, LOC129934724, LOC129934725, LOC129934726, LOC129934727, LOC129934728, LOC129934729, LOC129934730, LOC129934731, LOC129934732, LOC129934733, LOC129934734, LOC129934735, LOC129934736, LOC129934737, LOC129934738, LOC129934739, LOC129934740, LOC129934741, LOC129934742, LOC129934743, LOC129934744, LOC129934745, LOC129934746, LOC129934747, LOC129934748, LOC129934749, LOC129934750, LOC129934751, LOC129934752, LOC129934753, LOC129934754, LOC129934755, LOC129934756, LOC129934757, LOC129934758, LOC129934759, LOC129934760, LOC129934761, LOC129934763, LOC129934764, LOC129934765, LOC129934766, LOC129934767, LOC129934768, LOC129934769, LOC129934770, LOC129934771, LOC129934772, LOC129934773, LOC129934774, LOC129934775, LOC129934776, LOC129934777, LOC129934778, LOC129934779, LOC129934780, LOC129934781, LOC129934782, LOC129934783, LOC129934784, LOC129934785, LOC129934786, LOC129934787, LOC129934788, LOC129934789, LOC129934790, LOC129934791, LOC129934792, LOC129934793, LOC129934794, LOC129934795, LOC129934796, LOC129934797, LOC129934798, LOC129934799, LOC129934800, LOC129934801, LOC129934802, LOC129934803, LOC129934804, LOC129934805, LOC129934806, LOC129934807, LOC129934808, LOC129934809, LOC129934810, LOC129934811, LOC129934812, LOC129934813, LOC129934814, LOC129934815, LOC129934816, LOC129934817, LOC129934818, LOC129934819, LOC129934820, LOC129934821, LOC129934822, LOC129934823, LOC129934824, LOC129934825, LOC129934826, LOC129934827, LOC129934828, LOC129934829, LOC132088751, LOC132088752, LOC132088753, LOC440910, LYPD1, MAP3K19, MAP3K2, MAP3K2-DT, MARCO, MGAT5, MIR3679, MIR4783, MIR4784, MIR5590, MIR663B, MIR9986, MYO7B, MZT2A, MZT2B, NCKAP5, NCKAP5-AS1, NCKAP5-AS2, NIFK, NIFK-AS1, PLEKHB2, POLR2D, POTEE, POTEF, POTEF-AS1, POTEI, POTEJ, PROC, PTPN18, PTPN4, RAB6C, RAB6C-AS1, RAB6D, RALB, RNU4ATAC, SAP130, SCTR, SCTR-AS1, SFT2D3, SMIM39, SMPD4, STEAP3, STEAP3-AS1, TEX51, TFCP2L1, THORLNC, TMEM163, TMEM177, TMEM185B, TMEM37, TRE-TTC1-1, TSN, TUBA3D, TUBA3E, UGGT1, WDR33, ZNF806
See casesPathogenic
(May 6, 2011)
no assertion criteria provided
3.
GRCh37:
Chr2:119445405-122379390
GRCh38:
Chr2:118687829-121621814
See casesPathogenic
(Mar 10, 2014)
no assertion criteria provided
4.
GRCh37:
Chr2:122135169
GRCh38:
Chr2:121377593
CLASP1, RNU4ATACR1124H, R1151H, R1183H, R1204H, R1115H, R1122H, R1116HInborn genetic diseasesUncertain significance
(Jun 11, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr2:122217658
GRCh38:
Chr2:121460082
CLASP1, RNU4ATACY359CInborn genetic diseasesUncertain significance
(Jul 6, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr2:122288193
GRCh38:
Chr2:121530617
CLASP1, RNU4ATACnot providedLikely benign
(Jul 10, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr2:122288213
GRCh38:
Chr2:121530637
CLASP1, RNU4ATACnot providedBenign
(Jul 9, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr2:122288257
GRCh38:
Chr2:121530681
CLASP1, RNU4ATACnot providedLikely benign
(Jul 10, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr2:122288407
GRCh38:
Chr2:121530831
CLASP1, RNU4ATACnot providedBenign
(Jul 10, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr2:122288415
GRCh38:
Chr2:121530839
CLASP1, RNU4ATACnot providedBenign
(Jul 10, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr2:122288445
GRCh38:
Chr2:121530869
CLASP1, RNU4ATACnot providedBenign
(Jul 10, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr2:122288456
GRCh38:
Chr2:121530880
CLASP1, RNU4ATACnot providedUncertain significance
(Apr 29, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr2:122288457
GRCh38:
Chr2:121530881
CLASP1, RNU4ATACnot providedUncertain significance
(Feb 8, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr2:122288457
GRCh38:
Chr2:121530881
CLASP1, RNU4ATACnot providedUncertain significance
(Nov 1, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr2:122288458
GRCh38:
Chr2:121530882
RNU4ATAC, CLASP1not providedUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr2:122288458
GRCh38:
Chr2:121530882
RNU4ATAC, CLASP1not providedUncertain significance
(Apr 19, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr2:122288459
GRCh38:
Chr2:121530883
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 18, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr2:122288460
GRCh38:
Chr2:121530884
CLASP1, RNU4ATACnot providedUncertain significance
(May 30, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr2:122288460
GRCh38:
Chr2:121530884
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr2:122288460
GRCh38:
Chr2:121530884
CLASP1, RNU4ATACnot providedUncertain significance
(Jun 1, 2020)
criteria provided, single submitter
21.
GRCh37:
Chr2:122288461-122288462
GRCh38:
Chr2:121530885-121530886
CLASP1, RNU4ATACnot providedUncertain significance
(Jan 4, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr2:122288461
GRCh38:
Chr2:121530885
CLASP1, RNU4ATACRNU4ATAC-related spliceosomopathies, not providedConflicting interpretations of pathogenicity
(Jun 19, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr2:122288462
GRCh38:
Chr2:121530886
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr2:122288463
GRCh38:
Chr2:121530887
CLASP1, RNU4ATACnot provided, Roifman syndromeConflicting interpretations of pathogenicity
(May 2, 2023)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr2:122288463
GRCh38:
Chr2:121530887
RNU4ATAC, CLASP1Lowry-Wood syndromeLikely pathogenic
(Jul 16, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr2:122288463
GRCh38:
Chr2:121530887
CLASP1, RNU4ATACnot provided, RNU4ATAC-related condition, Neurodevelopmental delay,
Short stature, Craniosynostosis syndrome, Cardiomyopathy,
Microcephaly, not specified, Spondyloepiphyseal dysplasia congenita
Conflicting interpretations of pathogenicity
(Jan 18, 2023)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr2:122288465
GRCh38:
Chr2:121530889
RNU4ATAC, CLASP1not providedUncertain significance
(Jan 20, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:122288466-122288467
GRCh38:
Chr2:121530890-121530891
RNU4ATAC, CLASP1not providedUncertain significance
(Oct 19, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr2:122288466
GRCh38:
Chr2:121530890
RNU4ATAC, CLASP1not providedUncertain significance
(Sep 21, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr2:122288466
GRCh38:
Chr2:121530890
CLASP1, RNU4ATACnot providedUncertain significance
(Feb 3, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr2:122288466-122288468
GRCh38:
Chr2:121530890-121530892
CLASP1, RNU4ATACnot providedUncertain significance
(Nov 3, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr2:122288467
GRCh38:
Chr2:121530891
CLASP1, RNU4ATACnot providedUncertain significance
(May 9, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr2:122288467
GRCh38:
Chr2:121530891
CLASP1, RNU4ATACnot providedUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:122288467
GRCh38:
Chr2:121530891
RNU4ATAC, CLASP1not providedUncertain significance
(Jun 3, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr2:122288468
GRCh38:
Chr2:121530892
CLASP1, RNU4ATACnot providedUncertain significance
(Jun 24, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr2:122288468
GRCh38:
Chr2:121530892
CLASP1, RNU4ATACRoifman syndrome, RNU4ATAC-related condition, not provided,
Roifman syndrome, Osteodysplastic primordial dwarfism, type 1, Lowry-Wood syndrome
Conflicting interpretations of pathogenicity
(Sep 1, 2023)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr2:122288469
GRCh38:
Chr2:121530893
RNU4ATAC, CLASP1not providedUncertain significance
(Sep 25, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr2:122288470-122288471
GRCh38:
Chr2:121530894-121530895
RNU4ATAC, CLASP1not providedUncertain significance
(Aug 2, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr2:122288470
GRCh38:
Chr2:121530894
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 9, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr2:122288470
GRCh38:
Chr2:121530894
CLASP1, RNU4ATACnot providedUncertain significance
(Jul 25, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr2:122288471
GRCh38:
Chr2:121530895
RNU4ATAC, CLASP1not providedUncertain significance
(Jul 9, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr2:122288471
GRCh38:
Chr2:121530895
CLASP1, RNU4ATACIntellectual disability, Short stature, Roifman syndrome,
Lowry-Wood syndrome, Osteodysplastic primordial dwarfism, type 1, Roifman syndrome,
not provided
Pathogenic/Likely pathogenic
(Jul 1, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr2:122288472
GRCh38:
Chr2:121530896
CLASP1, RNU4ATACnot provided, RNU4ATAC-related condition, Roifman syndrome
Conflicting interpretations of pathogenicity
(May 2, 2023)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr2:122288472
GRCh38:
Chr2:121530896
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr2:122288473
GRCh38:
Chr2:121530897
CLASP1, RNU4ATACRoifman syndrome, not providedConflicting interpretations of pathogenicity
(Dec 18, 2021)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr2:122288474
GRCh38:
Chr2:121530898
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr2:122288476
GRCh38:
Chr2:121530900
RNU4ATAC, CLASP1not providedUncertain significance
(Jun 24, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr2:122288476
GRCh38:
Chr2:121530900
CLASP1, RNU4ATACnot providedUncertain significance
(Feb 1, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr2:122288476
GRCh38:
Chr2:121530900
CLASP1, RNU4ATACnot providedUncertain significance
(Jan 27, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr2:122288477
GRCh38:
Chr2:121530901
CLASP1, RNU4ATACnot providedUncertain significance
(May 9, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr2:122288477
GRCh38:
Chr2:121530901
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 15, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr2:122288478
GRCh38:
Chr2:121530902
CLASP1, RNU4ATACnot providedLikely benign
(Aug 1, 2023)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr2:122288479
GRCh38:
Chr2:121530903
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 1, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr2:122288479
GRCh38:
Chr2:121530903
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr2:122288480
GRCh38:
Chr2:121530904
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr2:122288480
GRCh38:
Chr2:121530904
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr2:122288481-122288482
GRCh38:
Chr2:121530905-121530906
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr2:122288481
GRCh38:
Chr2:121530905
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr2:122288482
GRCh38:
Chr2:121530906
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr2:122288483
GRCh38:
Chr2:121530907
RNU4ATAC, CLASP1not providedUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr2:122288484
GRCh38:
Chr2:121530908
RNU4ATAC, CLASP1not providedUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr2:122288484
GRCh38:
Chr2:121530908
RNU4ATAC, CLASP1Osteodysplastic primordial dwarfism, type 1Likely pathogenicno assertion criteria provided
63.
GRCh37:
Chr2:122288485
GRCh38:
Chr2:121530909
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr2:122288485
GRCh38:
Chr2:121530909
CLASP1, RNU4ATACnot provided, Osteodysplastic primordial dwarfism, type 1Likely pathogenic
(Jul 23, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr2:122288486
GRCh38:
Chr2:121530910
CLASP1, RNU4ATACnot providedUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr2:122288487
GRCh38:
Chr2:121530911
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 14, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr2:122288487
GRCh38:
Chr2:121530911
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr2:122288488
GRCh38:
Chr2:121530912
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 26, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr2:122288489
GRCh38:
Chr2:121530913
RNU4ATAC, CLASP1not providedUncertain significance
(Jun 20, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr2:122288490
GRCh38:
Chr2:121530914
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr2:122288491
GRCh38:
Chr2:121530915
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 2, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr2:122288491
GRCh38:
Chr2:121530915
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr2:122288492
GRCh38:
Chr2:121530916
CLASP1, RNU4ATACRoifman syndrome, RNU4ATAC-related condition, not provided,
Spondyloepiphyseal dysplasia congenita, Roifman syndrome, Osteodysplastic primordial dwarfism, type 1,
Lowry-Wood syndrome
Conflicting interpretations of pathogenicity
(Jan 19, 2023)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:122288494
GRCh38:
Chr2:121530918
RNU4ATAC, CLASP1not providedUncertain significance
(Feb 10, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr2:122288494
GRCh38:
Chr2:121530918
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr2:122288495
GRCh38:
Chr2:121530919
CLASP1, RNU4ATACnot providedUncertain significance
(May 12, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr2:122288495
GRCh38:
Chr2:121530919
CLASP1, RNU4ATACnot providedPathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr2:122288496
GRCh38:
Chr2:121530920
RNU4ATAC, CLASP1not providedLikely benign
(Oct 31, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr2:122288497
GRCh38:
Chr2:121530921
CLASP1, RNU4ATACnot providedUncertain significance
(Oct 18, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr2:122288497
GRCh38:
Chr2:121530921
CLASP1, RNU4ATACnot providedLikely benign
(Oct 24, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr2:122288498
GRCh38:
Chr2:121530922
RNU4ATAC, CLASP1not providedLikely benign
(Sep 28, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr2:122288498
GRCh38:
Chr2:121530922
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr2:122288498
GRCh38:
Chr2:121530922
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr2:122288499
GRCh38:
Chr2:121530923
RNU4ATAC, CLASP1not providedUncertain significance
(Mar 20, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr2:122288500
GRCh38:
Chr2:121530924
RNU4ATAC, CLASP1not providedLikely benign
(Aug 16, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr2:122288500
GRCh38:
Chr2:121530924
CLASP1, RNU4ATACnot providedUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr2:122288501
GRCh38:
Chr2:121530925
CLASP1, RNU4ATACnot providedUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr2:122288501
GRCh38:
Chr2:121530925
CLASP1, RNU4ATACOsteodysplastic primordial dwarfism, type 1Likely pathogenicno assertion criteria provided
89.
GRCh37:
Chr2:122288501
GRCh38:
Chr2:121530925
CLASP1, RNU4ATACnot providedPathogenic
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr2:122288502
GRCh38:
Chr2:121530926
RNU4ATAC, CLASP1not providedUncertain significance
(Jun 20, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr2:122288502
GRCh38:
Chr2:121530926
CLASP1, RNU4ATACnot providedUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr2:122288503
GRCh38:
Chr2:121530927
RNU4ATAC, CLASP1Roifman syndrome, Lowry-Wood syndrome, Osteodysplastic primordial dwarfism, type 1,
not provided, RNU4ATAC-related spliceosomopathies, Roifman syndrome
Likely pathogenic
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr2:122288505
GRCh38:
Chr2:121530929
CLASP1, RNU4ATACRoifman syndrome, not providedConflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr2:122288505
GRCh38:
Chr2:121530929
RNU4ATAC, CLASP1Osteodysplastic primordial dwarfism, type 1Pathogenic
(Apr 8, 2011)
no assertion criteria provided
95.
GRCh37:
Chr2:122288506
GRCh38:
Chr2:121530930
CLASP1, RNU4ATACRoifman syndrome, RNU4ATAC-related condition, not provided,
Osteodysplastic primordial dwarfism, type 1, Roifman syndrome, Lowry-Wood syndrome,
Osteodysplastic primordial dwarfism, type 1
Pathogenic/Likely pathogenic
(Jul 1, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr2:122288507
GRCh38:
Chr2:121530931
CLASP1, RNU4ATACnot providedUncertain significance
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr2:122288507
GRCh38:
Chr2:121530931
CLASP1, RNU4ATACnot providedUncertain significance
(Nov 1, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr2:122288508
GRCh38:
Chr2:121530932
CLASP1, RNU4ATACnot provided, Lowry-Wood syndromeConflicting interpretations of pathogenicity
(Oct 1, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr2:122288508
GRCh38:
Chr2:121530932
RNU4ATAC, CLASP1not providedLikely pathogenic
(May 25, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr2:122288509
GRCh38:
Chr2:121530933
CLASP1, RNU4ATACnot providedUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination